Humilis US Focused Opportunities ETF (HIS)

$24.83 -0.15 (-0.60%)
Market Cap N/A
Revenue (ttm) N/A
Net Income (ttm) N/A
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin N/A
Debt to Equity Ratio N/A
Volume 407,051
Avg Vol N/A
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K N/A
Beta N/A
Analysts N/A
Price Target N/A
CNGLLC
CNGLLC May. 15 at 2:07 PM
$HIS Is this a BUY the Dip moment yet ?
0 · Reply
c2turbo
c2turbo Aug. 2 at 8:07 AM
The comment from the Eli Lilly executive is regarding the shortage of Tirzepatide. $HIMS compounds are based on Semaglutide. Remember that $HIMS board member Kåre Schultz a week ago told Bloomberg that the company has a "long future" in selling compunded Semaglutide. Could he be lying the very first day he joined the board in his first interviews with Bloomberg representing $HIMS? Sure, but it's highly unlikely. Could it be that the market has a better understanding of the shortage situation regarding Semaglutide than he has? Sure, but I would put more trust in the words from a person with 35 years of experience in this field, 25 of them at Novo Nordisk. But most importanatly, $HIS isn't about GLP-1. Medicines comes and goes. Better treatments for weight loss is on the way. The GLP-1 offer has to be an excellent opportunity for $HIMS to build their customer base. Remeber, one of $HIMS strong points is additional sales for existing customers
0 · Reply
Christam1302
Christam1302 Dec. 21 at 9:03 PM
$HIS ”The company is working on a plan that they hope will negate the reverse business". OMG what does that even mean???? I could have gotten my 11-year-old daughter to write a more professional and understandable quote, are you shitting me? This is who is running the show? Dear God save us all , is that even proper English?
0 · Reply
fla
fla Feb. 14 at 12:47 PM
$HIS keen eye for emerging technologies led to Nasdaq acquiring SMARTS Surveillance and Cinnober [15s. delayed]: Issued Press Release on F https://s.flashalert.me/kHElJ
0 · Reply
liteagilis
liteagilis Feb. 5 at 3:14 PM
$CSIQ curious why bulls on this board (looking at you mr carumba) didn’t even mention the Biden administration moderation of Chinese panel tariffs. Should be hugely bullish for this and $HIS no?
2 · Reply
fla
fla Sep. 28 at 2:17 PM
$HIS leadership team [15s. delayed]: Issued Press Release on September 28, 10:09:00: Babylon Appoints Stock Exchange Veteran as New Board https://s.flashalert.me/iKlVG
0 · Reply
TheSpiderKing
TheSpiderKing Aug. 12 at 10:32 AM
Recently deSPAC’d $MTTR $SKIN $HIS $ROVR all looking strong. They struggled some immediately after but they busting. $MUDS shareholder meeting august 25th with deSPAC to happen soon after (august 30?) $760M rev $140M Ebitda cash positive with Michael Eisner at the steering wheel of the Topps Company $MUDS
0 · Reply
W1nation
W1nation Jun. 7 at 1:27 PM
$HIS experience also includes roles at GoDaddy, Yahoo!, IBM, and Shazam where he developed and operated back-end architecture while leading engineering teams.
0 · Reply
ElliottwaveForecast
ElliottwaveForecast Jul. 13 at 11:49 PM
$HIS-HKG How we saw it back in March 2020 @ http://elliottwave-forecast.com when we were looking for a decline toward the blue box before the Index turned higher again. #Elliottwave #Hangseng #Indices #Trading
0 · Reply
ElliottwaveForecast
ElliottwaveForecast Jul. 13 at 10:06 AM
$HIS-HKG How we saw it back in March 2020 @ www.elliottwave-forecast.com when we were looking for a decline toward the blue box before the Index turned higher again. #Elliottwave #Hangseng #Indices #Trading
0 · Reply
Latest News on HIS
Humilis Investments' Brian Belski launches HIS, a new ETF

May 19, 2026, 3:32 PM EDT - 8 hours ago

Humilis Investments' Brian Belski launches HIS, a new ETF

CNGLLC
CNGLLC May. 15 at 2:07 PM
$HIS Is this a BUY the Dip moment yet ?
0 · Reply
c2turbo
c2turbo Aug. 2 at 8:07 AM
The comment from the Eli Lilly executive is regarding the shortage of Tirzepatide. $HIMS compounds are based on Semaglutide. Remember that $HIMS board member Kåre Schultz a week ago told Bloomberg that the company has a "long future" in selling compunded Semaglutide. Could he be lying the very first day he joined the board in his first interviews with Bloomberg representing $HIMS? Sure, but it's highly unlikely. Could it be that the market has a better understanding of the shortage situation regarding Semaglutide than he has? Sure, but I would put more trust in the words from a person with 35 years of experience in this field, 25 of them at Novo Nordisk. But most importanatly, $HIS isn't about GLP-1. Medicines comes and goes. Better treatments for weight loss is on the way. The GLP-1 offer has to be an excellent opportunity for $HIMS to build their customer base. Remeber, one of $HIMS strong points is additional sales for existing customers
0 · Reply
Christam1302
Christam1302 Dec. 21 at 9:03 PM
$HIS ”The company is working on a plan that they hope will negate the reverse business". OMG what does that even mean???? I could have gotten my 11-year-old daughter to write a more professional and understandable quote, are you shitting me? This is who is running the show? Dear God save us all , is that even proper English?
0 · Reply
fla
fla Feb. 14 at 12:47 PM
$HIS keen eye for emerging technologies led to Nasdaq acquiring SMARTS Surveillance and Cinnober [15s. delayed]: Issued Press Release on F https://s.flashalert.me/kHElJ
0 · Reply
liteagilis
liteagilis Feb. 5 at 3:14 PM
$CSIQ curious why bulls on this board (looking at you mr carumba) didn’t even mention the Biden administration moderation of Chinese panel tariffs. Should be hugely bullish for this and $HIS no?
2 · Reply
fla
fla Sep. 28 at 2:17 PM
$HIS leadership team [15s. delayed]: Issued Press Release on September 28, 10:09:00: Babylon Appoints Stock Exchange Veteran as New Board https://s.flashalert.me/iKlVG
0 · Reply
TheSpiderKing
TheSpiderKing Aug. 12 at 10:32 AM
Recently deSPAC’d $MTTR $SKIN $HIS $ROVR all looking strong. They struggled some immediately after but they busting. $MUDS shareholder meeting august 25th with deSPAC to happen soon after (august 30?) $760M rev $140M Ebitda cash positive with Michael Eisner at the steering wheel of the Topps Company $MUDS
0 · Reply
W1nation
W1nation Jun. 7 at 1:27 PM
$HIS experience also includes roles at GoDaddy, Yahoo!, IBM, and Shazam where he developed and operated back-end architecture while leading engineering teams.
0 · Reply
ElliottwaveForecast
ElliottwaveForecast Jul. 13 at 11:49 PM
$HIS-HKG How we saw it back in March 2020 @ http://elliottwave-forecast.com when we were looking for a decline toward the blue box before the Index turned higher again. #Elliottwave #Hangseng #Indices #Trading
0 · Reply
ElliottwaveForecast
ElliottwaveForecast Jul. 13 at 10:06 AM
$HIS-HKG How we saw it back in March 2020 @ www.elliottwave-forecast.com when we were looking for a decline toward the blue box before the Index turned higher again. #Elliottwave #Hangseng #Indices #Trading
0 · Reply
MarketBeat
MarketBeat Jan. 28 at 1:44 PM
Jefferies Financial Group Lowers H.I.S. FY2020 Earnings Estimates to $1.78 EPS (Previously $1.95). https://www.marketbeat.com/x/776371 $HIS
0 · Reply
MarketBeat
MarketBeat Dec. 16 at 6:25 AM
Jefferies Financial Group Lowers H.I.S. FY2020 Earnings Estimates to $1.95 EPS (Previously $2.21). https://www.marketbeat.com/x/762598 $HIS
0 · Reply
MarketBeat
MarketBeat Sep. 16 at 6:05 AM
Jefferies Financial Group Lowers H.I.S. FY2023 Earnings Estimates to $3.17 EPS (Previously $3.59). https://www.marketbeat.com/x/720764 $HIS
0 · Reply
MarketBeat
MarketBeat Sep. 13 at 10:42 AM
Jefferies Financial Group Lowers H.I.S. FY2019 Earnings Estimates to $1.80 EPS (Previously $1.88). https://www.marketbeat.com/x/720260 $HIS
0 · Reply
MarketBeat
MarketBeat Oct. 19 at 11:23 AM
Jefferies Financial Group Lowers H.I.S. FY2018 Earnings Estimates to $1.44 EPS (Previously $1.47). https://www.marketbeat.com/x/550376 $HIS
0 · Reply
Rco29264261
Rco29264261 Mar. 6 at 5:19 AM
$HIS A lifetime of happiness! No man alive could bear it: it would be hell on earth.
0 · Reply
benzinga
benzinga Jun. 23 at 11:55 AM
IHS Posts Upbeat Q2 Results, Lifts Outlook $HIS $IHS http://stks.co/r2M0u
0 · Reply
AlphaStreet
AlphaStreet Mar. 24 at 12:28 PM
$HIS 1Q15 PR: Segment Revenues: Americas $366MM; EMEA $127MM; APAC $53MM.
0 · Reply
AlphaStreet
AlphaStreet Mar. 24 at 12:25 PM
$HIS 1Q15 PR: Adjusted EPS $1.36 vs. $1.28 in 1Q14. Adjusted EBITDA $169MM vs. $156MM in 1Q14.
0 · Reply
AlphaStreet
AlphaStreet Mar. 24 at 12:18 PM
$HIS 1Q15 PR: Revenue $546MM vs. $524MM in 1Q14. Net income $39MM vs. $32MM in 1Q14.
0 · Reply
BidnessEtc
BidnessEtc Apr. 1 at 4:00 PM
China's PMI went up to 50.3 in March, higher than the value of 50.2 recorded in Feb http://stks.co/c0OT8 $HIS $SHA $UKX $SPY $MACRO
0 · Reply